Senseonics Holdings, Inc.
Close on Oct 19, 2026
- Market cap
- $463.61M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 4, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | After market close | $14.50M | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | After market close | $11.70M | $-0.71 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 2, 2026 | After market close | $14.30M | $-0.46 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 5, 2025 | After market close | $8.10M | $-0.43 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 6, 2025 | After market close | $6.60M | $-0.02 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | After market close | $6.30M | $-0.02 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 3, 2025 | After market close | $8.30M | $-0.02 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 7, 2024 | After market close | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 8, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 13, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 29, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| gross margin guidance | full-year | 58% to 61% | Raised |
| global net revenue guidance | full-year 2026 | $62.00M to $66.00M | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Senseonics filed with the SEC
Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Senseonics Announces Commencement of $80 Million
Material agreement · Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Senseonics Announces Pricing of $80 Million
Material agreement · Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
T erri t or y M anagers As s ocia t e T erritor y M an a ge rs R egional C lini c al M anagers Area M anagers
Material agreement · Results of operations · Regulation FD disclosure · Other events · EX-99.3 to Form 8-K
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Results of operations · EX-99 to Form 8-K
Senseonics Announces Preliminary Unaudited Revenue
Results of operations · Other events · EX-99.1 to Form 8-K
Senseonics Holdings, Inc. Reports Third Quarter Financial Results
Results of operations · EX-99 to Form 8-K
Senseonics Announces Preliminary Unaudited Revenue
Results of operations · EX-99.1 to Form 8-K
Senseonics Signs Memorandum of Understanding
Material agreement · New financial obligation · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Senseonics Holdings, Inc. Reports Second Quarter Financial Results
Results of operations · EX-99 to Form 8-K
Senseonics Announces Commencement of $50 Million
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Senseonics Announces Pricing of $50 Million
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
THE WORLD’S FIRST AND ONLY LONG-TERM CONTINUOUS GLUCOSE MONITORING SYSTEM
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Senseonics Holdings, Inc. Reports First Quarter Financial Results
Results of operations · EX-99 to Form 8-K
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Senseonics Holdings, Inc. Announces Business
Results of operations · Other events · EX-99.1 to Form 8-K
3 3 To transform lives in the global diabetes community with differentiated, long - term implantable glucose management technology. OUR MISSION
Regulation FD disclosure · EX-99.1 to Form 8-K
Senseonics Holdings, Inc. Reports Third
Results of operations · EX-99.1 to Form 8-K
$16 million upfront with the potential for an additional $16 million
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS SECOND QUARTER 2024 FINANCIAL
Results of operations · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. PROVIDES BUSINESS
Regulation FD disclosure · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS FIRST QUARTER 2024 FINANCIAL
Results of operations · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR
Results of operations · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS THIRD QUARTER 2023 FINANCIAL
Results of operations · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS SECOND QUARTER 2023 FINANCIAL
Results of operations · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
Results of operations · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR
Results of operations · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS THIRD QUARTER 2022 FINANCIAL
Results of operations · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS SECOND QUARTER 2022 FINANCIAL
Results of operations · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS FIRST QUARTER 2022
Results of operations · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL
Results of operations · EX-99.1 to Form 8-K
Senseonics Announces FDA Approval of the Eversense® E3 Continuous
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
SENSEONICS HOLDINGS, INC. REPORTS THIRD QUARTER 2021 FINANCIAL
Results of operations · EX-99.1 to Form 8-K